palmitoyl-pentapeptide-4, Matrixyl Synthe'6, pentapeptide-4 · Evidence-based safety and harm-reduction overview.
| Also known as | palmitoyl-pentapeptide-4, Matrixyl Synthe'6, pentapeptide-4 |
| Category | Peptide |
| pentapeptide | True |
| palmitic_acid_conjugate | True |
| typical_concentration | 2-5 percent |
| US legal status | Approved as a cosmetic ingredient (INCI: Palmitoyl Pentapeptide-4). Permitted in topical cosmetics in the EU and US under cosmetic regulations. Not a drug; regulated as cosmetic ingredient. No prescription or pharmaceutical designation. |
A synthetic pentapeptide (5 amino acids) conjugated to palmitic acid for enhanced penetration. Designed to stimulate collagen and glycosaminoglycan production in skin fibroblasts, supporting skin structure and elasticity.
Matrixyl binds to fibroblast growth factor receptors (FGFR) and other signaling pathways, upregulating type I and III collagen synthesis. Palmitic acid enhances skin penetration.
Developed by Lipotec in early 2000s as a collagen-stimulating cosmetic peptide. Marketed as Matrixyl and Matrixyl Synthe'6; widely adopted in premium skincare lines.
In vitro studies demonstrate increased collagen and hyaluronic acid production in human skin fibroblasts. Clinical cosmetic studies report modest improvements in skin firmness and wrinkle appearance over 4-8 weeks of topical use. Effects are incremental and require consistent application. Independent peer-reviewed research is limited; most data originates from cosmetic manufacturers.
Cosmetic formulations typically contain 2 to 5 percent Matrixyl. Optimal concentration appears 3 to 5 percent for efficacy and tolerance.
This is general research/context information, not medical advice or a recommended protocol.
Matrixyl works well in layered skincare with vitamin C, retinoids, niacinamide, and hyaluronic acid; standard cosmetic protocols apply.
If you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.
Compare testing optionsMatrixyl targets collagen production via fibroblast signaling, whereas other cosmetic peptides may target muscle relaxation or other pathways. Matrixyl is foundational-support focused.
No. Matrixyl is a cosmetic ingredient for topical formulations only. Injection is not standard and carries contamination and safety risks.
Cosmetic studies show measurable effects after 4-8 weeks of consistent daily use. Results are modest and incremental.
Most skin types tolerate Matrixyl well in cosmetic formulations. Very sensitive individuals may experience mild irritation; patch testing is prudent.
Matrixyl and retinoids have different mechanisms and efficacy profiles. Retinoids are more potent for anti-aging; Matrixyl is a gentler, complementary ingredient.
Medical & legal disclaimer. This site is for informational and harm-reduction purposes only. It is not medical advice and is not a substitute for a licensed healthcare professional. The compounds discussed are largely not approved by the FDA for human use and many are sold strictly as research chemicals 'not for human consumption.' Nothing here is an endorsement to purchase, possess, or use any substance. Laws vary by jurisdiction. Always consult a qualified physician and follow the law where you live.
Some links on this page may be affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes the safety information we publish.